Department of Medical Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Department of Internal Medicine, Seoul Medical Center, Seoul, Korea.
Cancer Res Treat. 2019 Oct;51(4):1632-1638. doi: 10.4143/crt.2019.009. Epub 2019 Apr 18.
Physician Orders for Life-Sustaining Treatment (POLST) form is a legal document for terminally ill patients to make medical decisions with physicians near the end-of-life. A multicenter prospective study was conducted to evaluate the feasibility of POLST administration in actual oncological practice.
Patients with terminal cancer, age ≥ 20 years, and capable of communicating were eligible. The primary endpoint was the completion rate of POLST. Data about physicians' or patients' barriers were also collected.
From June to December 2017, 336 patients from seven hospitals were eligible. Median patient age was 66 years (range, 20 to 94 years); 52.7% were male; and 60.4% had poor performance status. Primary cancer sites were hepato-pancreato-biliary (26.2%), lung (23.2%), and gastrointestinal (19.9%). Expected survival duration was 10.6±7.3 weeks, with 41.2% receiving hospice care, 37.9% showing progression after cancer treatment, and the remaining patients were under active treatment (15.8%) or initially diagnosed with terminal cancer (5.1%). POLST forms were introduced to 60.1% of patients, and 31.3% signed the form. Physicians' barriers were reluctance of family (49.7%), lack of rapport (44.8%), patients' denial of prognosis (34.3%), lack of time (22.7%), guilty feelings (21.5%), and uncertainty about either prognosis (21.0%) or the right time to discuss POLST (16.6%). The patients' barriers were the lack of knowledge/understanding of POLST (65.1%), emotional discomfort (63.5%), difficulty in decision-making (66.7%), or denial of prognosis (14.3%).
One-third of patients completed POLST forms, and various barriers were identified. To overcome such barriers, social engagement, education, and systematic support might be necessary.
医生签署的维持生命治疗指令(POLST)表是一种法律文件,用于在临终前让绝症患者与医生一起做出医疗决策。一项多中心前瞻性研究旨在评估 POLST 在实际肿瘤学实践中的可行性。
纳入标准为患有终末期癌症、年龄≥20 岁且能够沟通的患者。主要终点是 POLST 完成率。还收集了关于医生或患者障碍的数据。
2017 年 6 月至 12 月,来自 7 家医院的 336 名患者符合条件。患者中位年龄为 66 岁(范围为 20 至 94 岁);52.7%为男性;60.4%的患者表现状态不佳。主要癌症部位为肝胆胰(26.2%)、肺(23.2%)和胃肠道(19.9%)。预计生存时间为 10.6±7.3 周,41.2%的患者接受临终关怀,37.9%的患者在癌症治疗后出现进展,其余患者正在接受积极治疗(15.8%)或最初被诊断为终末期癌症(5.1%)。向 60.1%的患者介绍了 POLST 表格,31.3%的患者签署了表格。医生的障碍包括家属不愿意(49.7%)、缺乏融洽关系(44.8%)、患者否认预后(34.3%)、缺乏时间(22.7%)、内疚感(21.5%)和对预后(21.0%)或讨论 POLST 的正确时间(16.6%)不确定。患者的障碍包括对 POLST 的知识/理解不足(65.1%)、情绪不适(63.5%)、决策困难(66.7%)或否认预后(14.3%)。
三分之一的患者完成了 POLST 表格,确定了各种障碍。为了克服这些障碍,可能需要社会参与、教育和系统支持。